leisure time -WSS

leisure time

author：entertainment 2025-10-01 17:42:39 - browse：89823

An army of wooden figures under blue and pink lighting — biotech coverage from STAT — Adobe

Biotech startup ReNAgade Therapeutics is cutting staff just seven months after raising the largest Series A round in the industry this year.

ReNAgade launched in May with hopes of becoming a one-stop shop for medicines targeting RNA, the genetic blueprints that cells use to make proteins instrumental in numerous diseases. These types of medicines are in high demand following the advent of mRNA vaccines for Covid and RNA-silencing therapies made by companies like Alnylam Pharmaceuticals.

ReNAgade was able to capitalize on that excitement when it raised a $300 million Series A round led by MPM Capital’s BioImpact Capital and F2 Ventures. But in recent days, the company decided to lay off around 10% of its 100-person team, according to a company statement and former employees’ posts on social media.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Gene therapy for Afghan refugees’ infant will be fully covered

leisure time

hotspot

WSS

Medicare explains how it will choose drugs for negotiation

Feds fine Medicare Advantage plans for overcharging members

Drug firms test therapies to halt Alzheimer’s before symptoms arise

AstraZeneca bets AAV gene therapy will still deliver the goods

Updated Covid vaccine has 54% effectiveness, new study suggests

Complete sequence of Y chromosome published for first time

entertainment

leisure time

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Top private equity targets in 2023: cardiology, clinical trials, lasers

Hepatitis C has a cure — but many Americans still lack access to it

Neuroscience startup Neumora files for IPO

In age of alternative facts, a scholarly course on calling out crap

AI gets buy

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

AI gets buy

Dobbs anniversary: the lost opportunity of abortion as health care

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Wikipedia

Departing Stanford president retracts two papers

Apellis safety probe of eye disease drug centers on injection needle

Bernie brings in new pharma CEOs to talk drug prices

What AAP's gender

Appeals court upholds limits to abortion pill

Updated Covid vaccine has 54% effectiveness, new study suggests

leisure time

Wikipedia

hotspot

explore